Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | CA12 | O43570 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 1/20 | 0.37 |
| ▸ | CA3 | P07451 | 1/20 | 0.37 |
| ▸ | CA4 | P22748 | 1/20 | 0.37 |
| ▸ | CA6 | P23280 | 1/20 | 0.37 |
| ▸ | CA5A | P35218 | 1/20 | 0.37 |
| ▸ | CA7 | P43166 | 1/20 | 0.37 |
| ▸ | CA9 | Q16790 | 1/20 | 0.37 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.37 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.37 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.37 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28678145 | 1.00 | ALDH1A1 (0.37) | ALDH1A1CA12CA1CA3CA4 | |
| SCHEMBL403269 | 0.79 | ALDH1A1 (0.54) | ALDH1A1CA12CA1CA3CA4 | |
| SCHEMBL29597557 | 0.79 | ALDH1A1 (0.54) | ALDH1A1CA12CA1CA3CA4 | |
| SCHEMBL28901253 | 0.77 | ALDH1A1 (0.52) | ALDH1A1CA12CA1CA3CA4 | |
| Naphthalene SCHEMBL27552802 | 0.77 | CYP2A6 (0.38) | — | |
| Naphthalene SCHEMBL19066813 | 0.77 | CYP2A6 (0.38) | — | |
| Indole SCHEMBL27451878 | 0.76 | AHR (0.59) | ALDH1A1CA1CA4CA6 | |
| Carbazole SCHEMBL27896194 | 0.75 | ALDH1A1 (0.52) | ALDH1A1 | |
| Carbazole SCHEMBL27823425 | 0.75 | ALDH1A1 (0.52) | ALDH1A1 | |
| Phenanthrene SCHEMBL28996800 | 0.74 | HSD17B10 (0.48) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240174588-A1 | METHOD FOR PREPARING CHIRAL ALKYL COMPOUNDS BY ASYMMETRIC HYDROGENATION OF OLEFINS CATALYZED BY IRON COMPLEX | ZHEJIANG UNIVERSITY (CN) | 2024-05-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240174588-A1 | METHOD FOR PREPARING CHIRAL ALKYL COMPOUNDS BY ASYMMETRIC HYDROGENATION OF OLEFINS CATALYZED BY IRON COMPLEX | SFXN1, SFXN3, HMOX2 | ALDH1A1 1208/4885CA12 1353/4885CA1 572/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.